Associate Director Analysis, Patient Engagement Data Insights at Information Technology Senior Management Forum
Indianapolis, Indiana, USA -
Full Time


Start Date

Immediate

Expiry Date

13 Sep, 25

Salary

162800.0

Posted On

15 Jun, 25

Experience

0 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

No

Skills

Drug Development

Industry

Information Technology/IT

Description

Posted Date
6/12/2025
Description
At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

2. PROVIDE STRATEGIC AND TECHNICAL LEADERSHIP FOR DATA INSIGHTS CAPABILITIES

  • Create preliminary models, tools, and reporting and support scaling for broader application.
  • Lead the development, release, and adoption of tools that create accessibility and pathways for engagement in Lilly clinical trials
  • Evaluate evolving business partner needs and recommend enhancements to existing tools and capabilities to support emerging opportunities
  • Provide business user requirements for existing or new technologies and related data sources
  • Develop and maintain relationships with other Lilly functions that enable data and analytics capabilities

MINIMUM QUALIFICATION REQUIREMENTS:

  • Bachelor’s Degree in a scientific, analytic, or health-related field
  • 3 - 5 years experience in drug development or science-related field
Responsibilities

The purpose of the Associate Director Analysis role is to support the design of clinical programs and trials by bringing together internal and external data and information (e.g. contemporary information on standard of care across the globe, understanding of patient pathways that can make trials more accessible within those geographies, interpretation of disease prevalence, etc.), analyses and insights to drive excellence in clinical trial design, enabling more efficient planning and execution to speed medicines to patients.

Loading...